Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

NCT04902443 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

58

Enrollment

NIH

Sponsor class

Conditions

Viral Associated Malignancies
Kaposi Sarcoma
EBV/KSHV-associated Lymphomas

Interventions

DRUG: Pomalidomide
DRUG: Nivolumab

Sponsor

National Cancer Institute (NCI)